Why the study?
Takotsubo syndrome can be complicated by life-threatening ventricular arrhythmias driven by sympathetic hyperactivity, prompting discussion of stellate ganglion blockade in its management.
Does stellate ganglion blockade improve management of arrhythmias in patients with Takotsubo syndrome?
Does stellate ganglion blockade improve management of arrhythmias in patients with Takotsubo syndrome?
Answers are grounded in this paper and cite their sources.
This review highlights the potential role of stellate ganglion blockade in managing life-threatening ventricular arrhythmias associated with Takotsubo syndrome.
Takotsubo syndrome (TTS) is an acute stress-induced cardiomyopathy characterized by transient left ventricular dysfunction, often mimicking acute myocardial infarction but without obstructive coronary artery disease. Although typically reversible, TTS can be complicated by serious adverse events, including life-threatening ventricular arrhythmias. The pathophysiology is complex but strongly linked to sympathetic nervous system hyperactivity and a surge in catecholamines, often termed "neurogenic stunned myocardium." This review discusses the role of arrhythmias in TTS, the influence of the autonomic nervous system, and explores the rationale, mechanisms, and potential applications of stellate ganglion blockade, particularly left stellate ganglion blockade, in the management of TTS-related arrhythmias, illustrated by a clinical case.
No takes yet. Share an insight, caveat, or question.
Giuliana et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: